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The ‘classical’ swine H1N1 influenza A virus lineage was established after the devastating 1918
human pandemic virus entered domestic pig herds. A descendent of this lineage recently
re-emerged in humans as the 2009 pandemic H1N1 virus. Adaptation in pigs has led to several
changes in the multifunctional viral NS1 protein as compared with the parental 1918 virus, most
notably a K217E substitution that abolishes binding to host Crk/CrkL signalling adapters, and an
11 aa C-terminal truncation. Using reverse genetics, we reintroduced both these features into a
prototype 2009 H1N1 strain, A/California/04/09. Restoration of Crk/CrkL binding or extension of
NS1 to 230 aa had no impact on virus replication in human or swine cells. In addition, minimal
effects on replication, pathogenicity and transmission were observed in mouse and ferret models.
Our data suggest that the currently circulating 2009 H1N1 virus is optimized to replicate
efficiently without requiring certain NS1 functions.
Since emerging in April 2009, an antigenically novel swine-
origin H1N1 influenza A virus has spread throughout the
world, causing the first influenza pandemic of the 21st
century. Like most seasonal influenza viruses, this new
virus is currently only associated with a mild self-limiting
illness in the majority of people, although some popula-
tions (e.g. the young, and those with certain chronic health
conditions) seem particularly susceptible to severe com-
plications (Jain et al., 2009).
We have begun to determine the effect that acquired
mutations may have on the replication and pathogenicity
of future circulating 2009 H1N1 virus strains. Here, we
concentrate on the viral NS1 protein, which performs a
number of functions to facilitate efficient virus propagation
and is considered a major virulence factor (reviewed by
Dundon & Capua, 2009; Hale et al., 2008b). Specifically,
NS1 blocks the activation of RIG-I, thereby inhibiting the
interferon-induction signalling cascade in infected cells
(Gack et al., 2009; Guo et al., 2007; Mibayashi et al., 2007;
Opitz et al., 2007). In addition, most (but not all) NS1
proteins can block the global post-transcriptional proces-
sing of cellular mRNAs, a second mechanism that probably
contributes to limiting host antiviral responses (Kochs
et al., 2007; Nemeroff et al., 1998; Noah et al., 2003;
Twu et al., 2007). NS1 also has well-characterized roles
in: (i) inhibiting specific antiviral effector proteins such
as 29-59-oligoadenylate synthetase (Min & Krug, 2006) and
dsRNA-activated protein kinase (Li et al., 2006; Min et al.,
2007); (ii) modulating host apoptosis (Schultz-Cherry
et al., 2001; Zhirnov et al., 2002); (iii) stimulating
phosphoinositide 3-kinase signalling (Hale et al., 2006);
and (iv) regulating viral RNA/protein synthesis (Burgui
et al., 2003; Min et al., 2007).
There has been a great deal of work aimed at correlating
virulence with strain-specific differences in the functions of
NS1. In this study, we examined the C-terminal portion of
NS1 beyond residue 202, which appears to be intrinsically
disordered (Hale et al., 2008a), and varies in length
depending upon the viral strain [total NS1 length can be
202–237 residues (Dundon & Capua, 2009)]. This flexible
tail has been implicated in the interaction of NS1 with
poly(A)-binding protein II (Li et al., 2001) and host
importins (Melen et al., 2007). Furthermore, the final four
C-terminal residues of many 230 aa long avian influenza A
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ligand (residues 227–230, e.g. ESEV or EPEV), which
unlike their human virus counterpart sequences have the
potential to bind to a plethora of PDZ domain-containing
proteins (Obenauer et al., 2006). Residues 212–217 of most
avian influenza A virus NS1 proteins also constitute a class
II SH3-binding motif (Finkelstein et al., 2007), which
displays remarkable binding specificity for the N-terminal
SH3 domains of the Crk/CrkL signalling adaptor proteins
(Heikkinen et al., 2008). The functional significance of
both these motif-based NS1–host interactions has yet to be
fully determined. Nevertheless, presence of a PDZ domain
ligand motif in NS1 appears to enhance viral pathogenicity,
at least in a mouse model (Jackson et al., 2008).
The NS1 protein of the currently circulating 2009 pandemic
H1N1 virus is only 219 aa long, and thus lacks any potential
C-terminal PDZ domain ligand motif. In addition, glutamic




segment of the 2009 H1N1 virus is derived from the North
American ‘classical’ swine H1N1 lineage, the precursor of
which is related to the 1918 pandemic H1N1 virus.Sequence
alignment of representative ‘classical’ swine H1N1 virus NS1
protein C-terminal tails since 1930 reveals that the
212PxxPxK
217 motif was present and maintained in the
swine virus population until around the mid-1950s, after
which glutamic acid replaced the lysine at position 217 (Fig. 1).
Furthermore, NS1 wasmaintained at a lengthof 230 aa until
the mid-1960s, when introduction of a stop codon resulted
in truncation at position 219 (Fig. 1). Both of these changes
have subsequently been retained in the ‘classical’ swine
H1N1 lineage until the present day, and have now emerged
with the novel 2009 H1N1 virus into the human population.
Given that human seasonal influenza A virus NS1 proteins
are generally 230 aa in length, and many have lysine at
position 217 [albeit commonly without Crk/CrkL binding
due to substitution of threonine for proline at 215
Fig. 1. Evolution of the ‘classical’ swine H1N1
influenza A virus NS1 protein C-terminal tail.
Alignment of sequences derived from the C
terminus (residues 201–230) of NS1 proteins
encoded by the 1918 H1N1 influenza A virus
(A/Brevig Mission/1/18; BM/1/18), represen-
tative North American ‘classical’ swine H1N1
viruses (1930–2008), and the 2009 pandemic
H1N1 virus (A/California/04/09; Cal/09). The
alignment is rooted with BM/1/18. Identity (.),
Crk/CrkL-binding residues (Q and grey shad-
ing) and stop codons (*) are indicated. The
sequences of rCal/09 mutant viruses gener-
ated in this study are shown (black box).
Highlighted aa (grey shading) in the rCal/09
STOPmut extended sequence indicate resi-
dues not observed in the ‘classical’ swine
H1N1 lineage that are found in the longer NS1
protein. Such changes are due to natural
‘silent’ mutations in the previously non-coding
sequence. For reference, the NS1 C-terminal
tail sequences of two recent human seasonal
H1N1 and H3N2 influenza A virus isolates are
shown (black box).
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tested the effect of making these individual changes on the
replication, pathogenicity and transmission of a prototype
2009 pandemic H1N1 influenza virus isolate, A/California/
04/09 (Cal/09).
As described previously (Hai et al., 2010), a plasmid-based
reverse genetics system was used to generate recombinant
mutant Cal/09 viruses expressing NS1 with either a C-
terminal extension of 11 aa, or an E217K aa substitution
(Fig. 1, lower box). As required by the Mount Sinai School
of Medicine institutional biosafety committee, work
involving these viruses was carried out in either a USDA-
and CDC-approved BSL3+ containment laboratory, or a
dedicated BSL2 laboratory with personnel adhering to
strict BSL3 working practices. Both mutant viruses were
created by changing a single nucleotide in the NS segment,
neither of which affected the NS2/NEP open reading frame
Fig. 2. In vitro characterization of the rCal/09 STOPmut and E217K viruses. (a) Plaque phenotype of rCal/09 WT, rCal/09
STOPmut and rCal/09 E217K viruses in MDCK cells. (b) Western blot determination of viral NP and NS1 protein expression in
MDCK cells infected for 12 h with the rCal/09 WT, rCal/09 STOPmut or rCal/09 E217K viruses (m.o.i. of 5 p.f.u. per cell).
Tubulin acted as a loading control. Molecular mass markers (kDa) are indicated. (c) Interaction of cellular CrkL with Cal/09 NS1.
GST-tagged NS1 (WT or E217K Cal/09) was expressed in 293T cells and pull-down (PD) assays performed using
glutathione–agarose beads. Following SDS-PAGE, precipitated proteins were detected by Western blot by using specific anti-
GST and anti-CrkL antibodies. These proteins were also detected in the soluble lysate prior to pull-down (‘Input’). Molecular
mass markers (kDa) are indicated. (d) Multicycle growth analysis of rCal/09 WT, rCal/09 STOPmut and rCal/09 E217K viruses
in primary differentiated HTBE cells, and the swine cell line PK-15 (e). Data points show mean values from triplicate experiments
and error bars represent SD.
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changed from TGA to CGA, thus replacing the existing
stop codon with an arginine codon (as found in most
human influenza A virus NS1 proteins). This extends the
NS1 ORF to 230 codons, at which point a natural stop
codon is present. The aa sequence of this extended tail is
highly similar to that of previously circulating ‘classical’
swine H1N1 influenza viruses in the 1960s, albeit with
three changes (Fig. 1, lower box: W220R, T225A and
S228T). Like its ‘classical’ swine predecessors, the four C-
terminal residues of this new NS1 tail do not make up a
consensus PDZ domain ligand motif.
Genotypes of the rescued, plaque-purified rCal/09 viruses
were confirmed by direct sequencing of the RT-PCR
products of the entire NS segments. In vitro characterization
of the engineered rCal/09 STOPmut virus revealed that both
this and therCal/09wild-type (WT)virushad similarplaque
phenotypes in Madin–Darby canine kidney (MDCK) cells
(Fig. 2a). Interestingly, the rCal/09 E217K virus displayed a
small-plaque phenotype (Fig. 2a). Western blot analysis
confirmed that relative levels of viral NS1 and NP proteins
were identical in infected MDCK cells for all three viruses,
suggesting no gross differences in mutant NS1 protein
expression or stability [m.o.i. of 5 p.f.u. per cell, 12 h post-
infection; Fig. 2(b) and data not shown]. We were unable to
resolve any migrational differences between the 219 aa WT
NS1 protein and the 230 aa STOPmut NS1 protein by SDS-
PAGE (Fig. 2b). However, we confirmed that the single
E217K aa change was able to confer CrkL-binding activity to
the Cal/09 NS1 protein. Glutathione S-transferase (GST)
fused to either WT Cal/09 NS1 or Cal/09 NS1-E217K was
expressed in human embryonic kidney (293T) cells, and
protein lysates were subjected to GST pull-down assays.
Analysis of precipitated proteins by Western blot revealed
that endogenous CrkL was only co-precipitated with the
Cal/09-NS1 E217K mutant, and not with WT Cal/09 NS1
(Fig. 2c, upper panel). Analysis of whole-cell lysates
confirmed similar expression levels of the input proteins
(Fig. 2c, lower panel). We also assessed replication of the
three rCal/09 viruses in primary differentiated human
tracheobronchial epithelial cells (HTBEs) and the swine cell
line PK-15. As shown in Fig. 2(d and e) both the rCal/09
STOPmut and E217K viruses grew with similar kinetics to
WT during multicycle growth analyses in both human and
swine cell-types (input m.o.i. of 0.001 p.f.u. per cell).
To test whether the increased length of NS1 or its ability to
bind Crk/CrkL would affect in vivo replication and/or
pathogenicity of the 2009 H1N1 virus, we initially
compared the rCal/09 WT, rCal/09 STOPmut and rCal/
09 E217K viruses in the highly susceptible DBA/2J mouse
model (Boon et al., 2009; Srivastava et al., 2009). All animal
procedures were performed in accordance with the
Institutional Animal Care and Use Committee guidelines
of Mount Sinai School of Medicine, and were carried out
in a BSL3 containment laboratory. Seven-week-old female
DBA/2J mice (The Jackson Laboratory, ME, USA) were
anaesthetized using ketamine–xylazine, infected with 10
5
p.f.u. of each virus (or PBS alone, 50 ml intranasally, n55),
and body weights were monitored for 14 days. The average
maximum body weight loss was similar for all three virus-
infected groups (Table 1, upper panel), whilst mice in the
PBS-treated group did not lose any weight. In parallel,
lungs were excised from euthanized mice and used to
determine viral titres. All three viruses appeared to reach
similar mean peak infectious titres at day 2, and no
differences between virus titres were observed at day 4
(Table 1, upper panel). However, the rCal/09 STOPmut
virus seemed to be cleared marginally faster than both the
WT and E217K viruses, as evidenced by viral titres on day 7
(Table 1, upper panel).






Day 2 lung titre
(log10±SD)D
Day 4 lung titre
(log10±SD)D
Day 7 lung titre
(log10±SD)D
rCal/09 WT 16.1±2.8 6.8±0.2 5.8±0.1 4.9±0.2
rCal/09 STOPmut 16.0±3.3 6.7±0.2 5.7±0.2 3.9±0.5






NT titre (log10)§ Tracheal titre (log10)§ Lung titre (log10)§
rCal/09 WT (2/2) and (2/2) 6.1 (5.9, 6.2) 3.3 (3.2, 3.4) 4.3 (3.4, 5.2)
rCal/09 STOPmut (2/2) and (2/2) 5.9 (5.7, 6.0) 2.9 (2.4, 3.5) 3.9 (3.4, 4.4)
rCal/09 E217K (2/2) and (2/2) 4.8 (4.7, 4.9) 2.8 (2.3, 3.4) 3.4 (3.4, 3.5)
*Body weights of infected mice were determined daily. Mean maximum body weight loss (typically days 7 or 8 post-infection) is indicated (n55).
DMean lung titres from three mice per group.
dTransmission events were scored after determining daily nasal wash titres from infected ferrets (n52), direct contact ferrets (n52) and aerosol
(large- and small-respiratory droplet) contact ferrets (n52).
§Mean viral titres in nasal turbinates (NT), trachea and lungs were determined on day 5 post-infection (n52). Results from individual replicates are
shown in parentheses.
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STOPmut and rCal/09 E217K viruses in a ferret model. All
ferret procedures were performed in accordance with the
Institutional Animal Care and Use Committee guidelines
of the University of Maryland, and were carried out in a
USDA-approved BSL3+ containment laboratory. The
basic transmission study scheme consisted of duplicate
groups of three 6–8-month-old female Fitch ferrets (Triple
F Farms, PA USA): one infected intranasally with 10
6
TCID50 of virus in PBS (600 ml per nostril), one infected by
direct contact and one infected by respiratory droplet
contact. Nasal washes were collected daily and viral titres
were determined in order to assess transmission events.
The experimental details were essentially as described
previously (Sorrell et al., 2009). Although we noted slightly
higher virus shedding with the WT rCal/09 virus (data not
shown), all three viruses transmitted equally efficiently to
other ferrets by both direct contact and respiratory droplet
routes (Table 1, lower panel). The amount of infectious
virus present in different parts of the ferret respiratory tract
was also determined at day 5 post-infection. All viruses
reached similar titres in the trachea and lungs; however, the
rCal/09 E217K virus grew to titres approximately 10-fold
lower than both WT and STOPmut viruses in nasal
turbinates (Table 1, lower panel).
In summary, we have investigated the potential effects that
specific NS1 mutations may have on the replication and
virulence of the emergent 2009 pandemic H1N1 virus. We
concentrated on the C-terminal tail of this NS1 protein due
to its uniquely short length (as compared with most
human influenza A virus strains), and its previously
published possible associations with virulence (Heikkinen
et al., 2008; Jackson et al., 2008; Obenauer et al., 2006).
Although human influenza A virus NS1 proteins do not
generally have a consensus Crk/CrkL-binding motif, we
sought to assess the impact of the E217K aa substitution as
it has already arisen naturally in a human 2009 H1N1 virus
isolate (A/Wisconsin/629-D00022/09), and Crk/CrkL bind-
ing is a feature of both highly pathogenic avian influenza A
viruses and the devastating 1918 pandemic virus
(Heikkinen et al., 2008). Overall, our data indicate that
neither the C-terminal extension of NS1 nor the E217K
substitution (both resulting from single nucleotide
changes) has a major effect on replication, virulence or
transmissibility of the novel 2009 H1N1 virus. Thus, the
possible future detection of these viruses in the human
population may not be an immediate cause for concern.
From a basic science perspective, our work also directly
addresses the role of Crk/CrkL binding and natural NS1 tail
length variation on influenza A virus replication and
pathogenicity. Although we saw limited impact in our
systems, we do not exclude the possibility that biological
effects may be more apparent with different virus strains or
host species. Indeed, the current 2009 H1N1 virus genetic
constellation may already be optimized to function so
efficiently that gain of new NS1 activities disrupts a subtle
virus–host equilibrium, thus leading to slight attenuation
of the virus. This hypothesis is also borne out by the
observations of others, who have additionally been unable
to experimentally increase replication of the 2009 H1N1
virus by reverse genetics methods (Hai et al., 2010; Herfst
et al., 2010). Clearly, it will be worth monitoring the
natural evolution of this swine-origin virus, along with its
unique NS1 protein, now that it is under human selection
pressures.
Note Added in Proof
A naturally-occurring 2009 pandemic H1N1 virus
(A/Australia/79/2009) expressing a 230 aa long NS1 protein
has recently been isolated from a human patient. The 11 aa
NS1 extension is the result of a change in codon 220 from
TGA to TGG, thus encoding the swine consensus residue
W220. This single nucleotide change also results in an
amino-acid substitution in NS2/NEP.
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